We identify the adaptor protein Shc as a critical mediator of the Alk5 force-response and reveal that genetic targeting of endothelial Shc reduces EndMT and atherosclerosis in areas of disturbed flow. The gene discussed is SHC1; the disease is atherosclerosis.